Risk of GERD-Related Disorders in Obese Patients on PPI Therapy: a Population Analysis

BACKGROUND: Increasing prevalence of obesity has shown an associated increase in gastroesophageal reflux disease (GERD)-related diseases. Proton pump inhibitor (PPI) therapy has been demonstrated to reduce the incidence of such diseases. The study’s aim was to analyze the Clinical Practice Research...

Descripción completa

Detalles Bibliográficos
Autores principales: Erridge, Simon, Moussa, Osama M., Ziprin, Paul, Darzi, Ara, Purkayastha, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132732/
https://www.ncbi.nlm.nih.gov/pubmed/29717405
http://dx.doi.org/10.1007/s11695-018-3246-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132732/
https://www.ncbi.nlm.nih.gov/pubmed/29717405
http://dx.doi.org/10.1007/s11695-018-3246-4

Ejemplares similares